Distinguished in Syringoma

Dr. Sandra Johnson

Dermatology
Office
5921 Riley Park Dr, 
Fort Smith, AR 

Distinguished in Syringoma
Office
5921 Riley Park Dr, 
Fort Smith, AR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sandra Johnson is a Dermatologist in Fort Smith, Arkansas. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of Syringoma. Her top areas of expertise are Rosacea, Acne, Sebaceous Adenoma, and Syringocystadenoma Papilliferum.

Her clinical research consists of co-authoring 29 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in AR
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HMO Partners
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
QualChoice
  • MEDICARE MAPD
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Office
5921 Riley Park Dr, Fort Smith, AR 72916
Call: 479-649-3376
Other Locations
Alma Pharmacy Inc
195 Highway 64 E, Alma, AR 72921
Call: 479-649-3376

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
A Pragmatic Trial of Home Versus Office Based Narrow Band Ultraviolet B Phototherapy for the Treatment of Psoriasis
A Pragmatic Trial of Home Versus Office Based Narrow Band Ultraviolet B Phototherapy for the Treatment of Psoriasis
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Enrollment Status: Completed
Publish Date: June 04, 2019
Intervention Type: Other, Biological
Study Phase: Phase 2
View 8 Less Clinical Trials

29 Total Publications

The Current Landscape of Treatment of Warts.
The Current Landscape of Treatment of Warts.
Journal: Journal of drugs in dermatology : JDD
Published: December 02, 2025
View All 29 Publications
Similar Doctors
Advanced in Syringoma
Dr. Chelsea Meltzer
Dermatology
Advanced in Syringoma
Dr. Chelsea Meltzer
Dermatology

Johnson Dermatology Clinic PLLC

5921 Riley Park Dr, 
Fort Smith, AR 
 (0.1 miles away)
479-649-3376
Experience:
10+ years
Languages Spoken:
English
See accepted insurances

Chelsea Meltzer is a Dermatologist in Fort Smith, Arkansas. Dr. Meltzer has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Syringoma. Her top areas of expertise are Sebaceous Adenoma, Syringocystadenoma Papilliferum, Syringoma, and Seborrheic Keratosis.

Advanced in Syringoma
Dr. Angela Styles
Dermatology
Advanced in Syringoma
Dr. Angela Styles
Dermatology

Angela Styles MD Dermatology & Dermatopathology PLLC

201 S Rogers St, 
Clarksville, AR 
 (53.1 miles away)
479-754-4333
Languages Spoken:
English
See accepted insurances

Angela Styles is a Dermatologist in Clarksville, Arkansas. Dr. Styles is rated as a Distinguished provider by MediFind in the treatment of Syringoma. Her top areas of expertise are Actinic Keratosis, Warts, Seborrheic Keratosis, and Universal Acquired Melanosis.

Experienced in Syringoma
Dr. Phillip Stites
Dermatology
Experienced in Syringoma
Dr. Phillip Stites
Dermatology

The Dermatology Center PLLC

7900 Dallas Street,, 
Fort Smith, AR 
 (5.8 miles away)
479-242-6647
Languages Spoken:
English
See accepted insurances

Phillip Stites is a Dermatologist in Fort Smith, Arkansas. Dr. Stites is rated as a Distinguished provider by MediFind in the treatment of Syringoma. His top areas of expertise are Seborrheic Keratosis, Warts, Actinic Keratosis, and Kaposiform Hemangioendothelioma.

VIEW MORE SYRINGOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Johnson's expertise for a condition
ConditionClose
    • Distinguished
    • Acne
      Dr. Johnson is
      Distinguished
      . Learn about Acne.
      See more Acne experts
    • Actinic Keratosis
      Dr. Johnson is
      Distinguished
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Rosacea
      Dr. Johnson is
      Distinguished
      . Learn about Rosacea.
      See more Rosacea experts
    • Sebaceous Adenoma
      Dr. Johnson is
      Distinguished
      . Learn about Sebaceous Adenoma.
      See more Sebaceous Adenoma experts
    • Syringocystadenoma Papilliferum
      Dr. Johnson is
      Distinguished
      . Learn about Syringocystadenoma Papilliferum.
      See more Syringocystadenoma Papilliferum experts
    • Syringoma
      Dr. Johnson is
      Distinguished
      . Learn about Syringoma.
      See more Syringoma experts
    • Advanced
    • Cutaneous T-Cell Lymphoma (CTCL)
      Dr. Johnson is
      Advanced
      . Learn about Cutaneous T-Cell Lymphoma (CTCL).
      See more Cutaneous T-Cell Lymphoma (CTCL) experts
    • Multiple Familial Trichoepithelioma
      Dr. Johnson is
      Advanced
      . Learn about Multiple Familial Trichoepithelioma.
      See more Multiple Familial Trichoepithelioma experts
    • Plaque Psoriasis
      Dr. Johnson is
      Advanced
      . Learn about Plaque Psoriasis.
      See more Plaque Psoriasis experts
    • Psoriasis
      Dr. Johnson is
      Advanced
      . Learn about Psoriasis.
      See more Psoriasis experts
    • Pustules
      Dr. Johnson is
      Advanced
      . Learn about Pustules.
      See more Pustules experts
    • Seborrheic Keratosis
      Dr. Johnson is
      Advanced
      . Learn about Seborrheic Keratosis.
      See more Seborrheic Keratosis experts
    View All 8 Advanced Conditions
    • Experienced
    • Atopic Dermatitis
      Dr. Johnson is
      Experienced
      . Learn about Atopic Dermatitis.
      See more Atopic Dermatitis experts
    • Cerebral Cavernous Malformation
      Dr. Johnson is
      Experienced
      . Learn about Cerebral Cavernous Malformation.
      See more Cerebral Cavernous Malformation experts
    • Cherry Angioma
      Dr. Johnson is
      Experienced
      . Learn about Cherry Angioma.
      See more Cherry Angioma experts
    • Comedones
      Dr. Johnson is
      Experienced
      . Learn about Comedones.
      See more Comedones experts
    • Contact Dermatitis
      Dr. Johnson is
      Experienced
      . Learn about Contact Dermatitis.
      See more Contact Dermatitis experts
    • Cutaneous Lupus Erythematosus (CLE)
      Dr. Johnson is
      Experienced
      . Learn about Cutaneous Lupus Erythematosus (CLE).
      See more Cutaneous Lupus Erythematosus (CLE) experts
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.